• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
  

PubMed=26095605; DOI=10.1016/j.stemcr.2015.05.010; PMCID=PMC4618251
Carlo Cusulin, Charles Chesnelong, Pinaki Bose, Misha Bilenky, Karen Kopciuk, Jennifer Ai-Wen Chan, J. Gregory Cairncross, Steven J.M. Jones, Marco Antonio Marra, Hema Artee Luchman, Samuel Weiss;
Precursor states of brain tumor initiating cell lines are predictive of survival in xenografts and associated with glioblastoma subtypes.
Stem Cell Reports 5:1-9(2015)

PubMed=26245525; DOI=10.1093/neuonc/nov143; PMCID=PMC4767234
Brad Davis, Yao-Qing Shen, Candice C. Poon, Hema Artee Luchman, Owen D.M. Stechishin, Carly Sabine Pontifex, Wei Wu, John J.P. Kelly, Michael D. Blough;
Terry Fox Research Institute Glioblastoma Consortium
Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
Neuro-oncol. 18:350-360(2016)

PubMed=27006494; DOI=10.1158/1078-0432.CCR-15-1798
Xue-Qing Lun, J. Connor Wells, Natalie Grinshtein, Jennifer C. King, Xiao-Guang Hao, Ngoc-Ha Dang, Xiu-Ling Wang, Ahmed Aman, David Uehling, Alessandro Datti, Jeffrey L. Wrana ...Show all 18 authors... , Jacob C. Easaw, Hema Artee Luchman, Samuel Weiss, J. Gregory Cairncross, David Ross Kaplan, Stephen M. Robbins, Donna L. Senger; Show fewer authors
Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma.
Clin. Cancer Res. 22:3860-3875(2016)